-
1
Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine
Published 2025-01-01Subjects: Get full text
Article -
2
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
Published 2024-12-01Subjects: “…Anti-CD20…”
Get full text
Article -
3
The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
Published 2024-03-01Subjects: Get full text
Article -
4
Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review
Published 2025-01-01Subjects: Get full text
Article -
5
Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study
Published 2025-01-01Subjects: Get full text
Article -
6
From fibrosis to granuloma: drug induced systemic sarcoidosis-like reaction after rituximab in a patient with primary Sjögren’s syndrome
Published 2024-12-01Subjects: Get full text
Article